Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial). J Am Coll Cardiol. 2007;49:1517 24. 274. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarc- tion: quantitative review of randomised trials. Lancet. 2006;367:579 88. Erratum in: Lancet. 2006;367:1656. 275. Van t Hof AWJ, Ten Berg J, Heestermans T, et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergo- ing primary angioplasty (On-TIME 2): a multicentre, double-blind, ran- domised controlled trial. Lancet. 2008;372:537 46. 276. El Khoury C, Dubien P-Y, Mercier C, et al. Prehospital high-dose tirofi- ban in patients undergoing primary percutaneous intervention: the AGIR- 2 study. Arch Cardiovasc Dis. 2010;103:285 92. 277. De Luca G, Bellandi F, Huber K, et al. Early glycoprotein IIb-IIIa inhibi- tors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient s data meta-analysis. J Thromb Haemost. 2011;9:2361 70. 278. Mehilli J, Kastrati A, Schulz S, et al. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percu- taneous coronary intervention after clopidogrel loading: a randomized double-blind trial. Circulation. 2009;119:1933 40. 279. Bellandi F, Maioli M, Gallopin M, et al. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardio- vasc Interv. 2004;62:186 92. 280. Romagnoli E, Burzotta F, Trani C, et al. Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI. Int J Cardiol. 2005;105:250 5. 281. Iversen A, Galatius S, Jensen JS. The optimal route of administration of the glycoprotein IIb/IIIa receptor antagonist abciximab during percutane- ous coronary intervention: intravenous versus intracoronary. Curr Car- diol Rev. 2008;4:293 9. 282. Kakkar AK, Moustapha A, Hanley HG, et al. 